Korro Bio, Inc. Employee Count
The employee counts Korro Bio, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 104; Filing 2025-03-18; Lease expense per employee $100,019.23.
- 2023-12-31: Employees (as filed) 101; Filing 2024-03-26; Lease expense per employee $80,000.00.
- Available history
- 2023-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 104 full-time | 2025-03-18 | $100,019.23 total lease cost |
| 2023-12-31 | 101 full-time | 2024-03-26 | $80,000.00 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |